Incidence, clinical course, and risk factors in the development of femoral pseudoaneurysm after atrial fibrillation ablation

被引:0
|
作者
Koyama, Takafumi [1 ]
Tobita, Kazuki [1 ]
Kawaguchi, Tatsuto [1 ]
Uchida, Shuhei [1 ]
Koyama, Eiji [1 ]
Kodera, Nobuhisa [1 ]
Tamaki, Yusuke [1 ]
Otomaru, Yuri [1 ]
Miyashita, Hirokazu [1 ]
Yamashita, Takayoshi [1 ]
Mizuno, Shingo [1 ]
Murakami, Masato [1 ]
Saito, Shigeru [1 ]
机构
[1] Shonan Kamakura Gen Hosp, Dept Cardiol, 1370-1 Okamoto, Kamakura, Kanagawa 2470072, Japan
关键词
aneurysm false*/etiology; atrial fibrillation; catheter ablation/adverse effects*; thrombin*; CATHETER ABLATION; REPAIR;
D O I
10.1002/joa3.12950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrevious studies have revealed the risk factors for femoral pseudoaneurysms (FPA). Most data on FPA are based on coronary and peripheral interventions, with limited studies focusing on atrial fibrillation (AF) ablation. However, patient backgrounds, anticoagulation regimens, and vascular access methods differ. In addition, a standard for managing FPA after AF ablation remains elusive due to the difficult nature of achieving thrombosis in pseudoaneurysms.MethodsThis single-center, retrospective, observational study included 2805 consecutive patients who underwent AF ablation between January 2016 and December 2021. All patients underwent femoral artery and vein punctures. Puncture sites were checked 1 day post-procedure.ResultsA total of 23 FPA patients were identified during the study period. Multivariate logistic regression analysis showed that hypertension (odds ratio 4.66, 95% confidence interval: 1.38-15.71; p = .0032) and warfarin use (odds ratio 3.83, 95% confidence interval: 1.40-10.45; p = .021) were significantly associated with the occurrence of FPA. The compression success rate was low (22%). There were nine and six patients in the endovascular treatment (EVT) and ultrasound-guided thrombin injection (UGTI) groups, respectively. The success rates were 100% and 84% in the EVT and UGTI groups, respectively. The length of hospital stay after FPA treatment was 2.1 days in the EVT group and 1.3 days in the thrombin group.ConclusionWe must be careful about post-procedural FPA, especially for hypertension and warfarin-using patients. Treatment of pseudoaneurysms with anticoagulants is unlikely to achieve hemostasis, and an early switch to invasive treatments, such as EVT, should be considered. In our investigation of atrial fibrillation ablation, we identified warfarin and hypertension as primary risk factors for femoral pseudoaneurysms. Our findings indicated that endovascular balloon inflation and thrombin injection were effective, with minimal complications and shortened hospital stays.image
引用
收藏
页码:894 / 900
页数:7
相关论文
共 50 条
  • [31] Atrial Fibrillation and Atrial Flutter in Heart Transplant Patients: Incidence, Risk Factors and Clinical Outcomes
    Dasari, T. W.
    Pavlovic-Surjancev, B.
    Patel, N.
    Williams, A. A.
    Ezidinma, P.
    Rupani, A.
    Sinacore, J. L.
    Loyala, A. L. Heroux
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S167 - S167
  • [32] Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter
    De Bortoli, Alessandro
    Shi, Li-Bin
    Ohm, Ole-Jorgen
    Hoff, Per Ivar
    Schuster, Peter
    Solheim, Eivind
    Chen, Jian
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (03) : 123 - 128
  • [33] Atrial Fibrillation After Cardiac Surgery: Incidence, Risk Factors, and Economic Burden
    Rostagno, Carlo
    La Meir, Mark
    Gelsomino, Sandro
    Ghilli, Lorenzo
    Rossi, Alessandra
    Carone, Enrico
    Braconi, Lucio
    Rosso, Gabriele
    Puggelli, Francesco
    Mattesini, Alessio
    Stefano, Pier Luigi
    Padeletti, Luigi
    Maessen, Jos
    Gensini, Gian Franco
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 24 (06) : 952 - 958
  • [34] Atrial fibrillation after lung cancer surgery: incidence, severity, and risk factors
    Muranishi, Yusuke
    Sonobe, Makoto
    Menju, Toshi
    Aoyama, Akihiro
    Chen-Yoshikawa, Toyohumi F.
    Sato, Toshihiko
    Date, Hiroshi
    SURGERY TODAY, 2017, 47 (02) : 252 - 258
  • [35] Atrial fibrillation after lung cancer surgery: incidence, severity, and risk factors
    Yusuke Muranishi
    Makoto Sonobe
    Toshi Menju
    Akihiro Aoyama
    Toyohumi F. Chen-Yoshikawa
    Toshihiko Sato
    Hiroshi Date
    Surgery Today, 2017, 47 : 252 - 258
  • [36] Incidence, timing, symptoms, and risk factors for atrial fibrillation after cardiac surgery
    Funk, M
    Richards, SB
    Desjardins, J
    Bebon, C
    Wilcox, H
    AMERICAN JOURNAL OF CRITICAL CARE, 2003, 12 (05) : 424 - 433
  • [37] Incidence, Risk Factors, and Outcomes of Atrial Fibrillation After Blood and/or Marrow Transplant
    Pinkhas, Daniel
    Ning, John
    Kim, Hyun
    Subramani, Matthew
    D'Souza, Anita
    Rubenstein, Jason
    CIRCULATION, 2020, 142
  • [38] Obstructive Sleep Apnea Is Closely Related to Cardiovascular Risk Factors, but Not to Clinical Recurrence of Atrial Fibrillation after Catheter Ablation: An Analysis of Atrial Fibrillation Patients
    Lee, Chan Joo
    Kim, Tae-Hoon
    Park, Sungha
    Pak, Hui-Nam
    PULSE, 2018, 6 (1-2) : 103 - 111
  • [39] Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation
    Cheema, Aamir
    Dong, Jun
    Dalal, Darshan
    Marine, Joseph E.
    Henrikson, Charles A.
    Spragg, David
    Cheng, Alan
    Nazarian, Saman
    Bilchick, Kenneth
    Sinha, Sunil
    Scherr, Daniel
    Almasry, Ibrahim
    Halperin, Henry
    Berger, Ronald
    Calkins, Hugh
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (04) : 387 - 391
  • [40] Atrial fibrillation after surgery of the lung: clinical analysis of risk factors
    Dyszkiewicz, W
    Skrzypczak, M
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1998, 13 (06) : 625 - 627